Kristen Knox is President and CEO of Microbiologics.
Microbiologics is a global leader in biological products and services, trusted by health care, life sciences and pharmaceutical organizations. For over 50 years, Microbiologics has empowered biopharmaceutical companies with cutting-edge biological control materials, assay services and expert consulting to combat infectious diseases.
Founded in 1971 as Environmental Protection Laboratories, Microbiologics pioneered contamination detection before advancing into lyophilized microorganisms. Today, its products support vaccine and therapeutic research in over 150 countries, accelerating medical breakthroughs. Headquartered in Saint Cloud, Minnesota, with facilities in California, Kentucky, Michigan and Germany, Microbiologics employs nearly 300 professionals.
The COVID-19 pandemic propelled its growth, reinforcing its adaptability. Kristen joined during this time, helping refocus Microbiologics’ strengths and guiding its evolution to expand into Precision Medicine. With the 2024 acquisition of SensID, Microbiologics is advancing precision oncology. Microbiologics is a catalyst for global health innovation, dedicated to scientific excellence for a safer, healthier world.